• Pollock, J.A.; Parker, H.K.* “Advances in the development of prodrugs as selective modulators of estrogen receptors.” J. Endocrin. Soc. 2022, 6(12), bvac158. PMID: 36381014

• Paul, L.*; Enkhbold, K.*; Robinson, S.*; Aye, T.T.*; Chung, Y.*; Pollock, J.A.; Norris, M.R. “Unravelling the role of [Ru(bpy)₂(OH₂)₂]²⁺ complexes in photo-activated chemotherapy.” J. Inorg. Biochem. 2022, 235, 111930. PMID: 35841722

• Airas, J.*; Bayas, C.A.*; Ousidi, A.N.; Itto, M.Y.A.; Auhmani, A.; Loubidi, M.; Esseffar, M.; Pollock, J.A.; Parish, C.A. “Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-Cov-2 M^Pro inhibitors.” Eur. J. Med. Chem. Reports 2022, 4, 100034.

• Berndsen, R.*; Cunningham, T.*; Kaelin, L.*; Callender, M.*; Boldog, W.D.*; Viering, B.*; King, A.*; Labban, N.*; Pollock, J.A.; Miller, H.B.; Blackledge, M.S. Identification and evaluation of brominated carbazoles as a novel antibiotic adjuvant scaffold in MRSA. ACS Med. Chem. Lett. 2022, 13, 483-491. ACS Editor’s Choice Article PMID: 35295086

• Labrecque, C.L.*; Hilton, C.N.*; Airas, J.*; Blake, A.*; Rubenstein, K.J.*; Parish, C.A.; Pollock, J.A. “Identification of phenazine-based MEMO1 small-molecule inhibitors: virtual screening, fluorescence polarization validation, and inhibition of breast cancer migration.” ChemMedChem 2021, 16, 1163-1171. PMID: 33332774

• Hughes, L.B.*; Labban, N.*; Conway, G.E.*; Pollock, J.A.; Leopold, M.C. “Adaptable xerogel-layered amperometric biosensor platforms on wire electrodes for clinically relevant measurements.” Sensors 2019, 19, 2584. PMID: 31174353

• Park, H.*; McEachon, J.D.*, Pollock, J.A. “Synthesis and characterization of hydrogen peroxide activated estrogen receptor beta ligands.” Bioorg. Med. Chem. 2019, 27, 2075-2082. doi: 10.1016/j.bmc.2019.04.003 PMID: 30967304 Graphical abstract chosen for cover

• Labban, N.*; Wayu, M.B.; Steele, C.M.*; Munoz, T.S.*; Pollock, J.A.; Case, W.S.; Leopold, M.C. “First generation amperometric biosensing of galactose with xerogel-carbon nanotube layer-by-layer assemblies.” Nanomaterials 2019, 9, 42. PMID: 30597967

• Wayu, M.B.; Pannell, M.J.*; Labban, N.*; Case, W.S.; Pollock, J.A.; Leopold, M.C. “Functionalized carbon nanotube adsorption interfaces for electron transfer studies of galactose oxidase.” Bioelectrochemistry 2019,125, 116-126. PMID: 30449323

• Pollock, J.A.; Sharma, N.; Ippagunta, S.K.; Redecke, V.; Häcker, H.; Katzenellenbogen, J.A. “Triaryl pyrazole Toll-like receptor signaling inhibitors: Structure-activity relationships governing pan- and selective signaling inhibitors.” ChemMedChem 2018, 13, 2208-2216. PMID: 30117269

• Newkirk, M.L.*; Rubenstein, K.J.*; Kim, J.Y.*; Labrecque, C.L.*; Airas, J.*; Taylor, C.A.*; Evans, H.E.*; McKoy, Q.*; Parish, C.A.; Pollock, J.A. “Analysis of MEMO1 binding specificity for ErbB2 using fluorescence polarization and molecular dynamics simulations.” Biochemistry 2018, 57, 5169-5181. PMID: 30067338 

• Ippagunta, S.K.; Pollock, J.A.; Sharma, N.; Lin, W.; Chen, T.; Tawaratsumida, K.; High, A.A.; Min, J.; Chen, Y.; Guy, R.K.; Redecke, V.; Katzenellenbogen, J.A.; Häcker, H. “Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins.” Sci. Signal. 2018, 11(543), eaaq1077. PMID: 30108181

• Pannell, M.J.*; Doll, E.E.*; Labban, N.*; Wayu, M.B.; Pollock, J.A.; Leopold, M.C. “Versatile sarcosine and creatinine biosensing schemes utilizing layer-by-layer construction of carbon nanotube-chitosan composite films.” J. Electroanal. Chem. 2018, 814, 20-30.

• Christenson, J.L.; Butterfield, K.T.; Spoelstra, N.S.; Norris, J.D.; Josan, J.S.; Pollock, J.A.; McDonnell, D.P.; Katzenellenbogen, B.S.; Katzenellenbogen, J.A.; Richer, J.K. “MMTV-PyMT and derived Met-1 mouse mammary tumor cells as models for studying the role of the androgen receptor in triple-negative breast cancer progression.” Horm. Canc. 2017, 8(2), 69-77. PMID: 28194662

• Pollock, J.A.; Wardell, S.E.; Parent, A.A.; Stagg, D.B.; Ellison, S.J.; Alley, H.M.; Chao, C.A.; Lawrence, S.A.; Stice, J.P. Spasojevic, I.; McDonnell, D.P.; Katzenellenbogen, J.A.; Norris, J.D. “Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer.” Nature Chem. Biol. 2016, 12(10), 795-801. PMID: 27501397

• Pollock, J.A.; Kim, S.H.; Katzenellenbogen, J.A. “Imidoyl dichlorides as new reagents for the rapid formation of 2-aminobenzimidazoles and related azoles.” Tetrahedron Lett. 2015, 56, 6097-6099. PMID: 26516292

• Nwachukwu, J. C.; Srinivasan, S.; Bruno, N. E.; Parent, A. A.; Hughes, T. S.; Pollock, J. A.; Gjyshi, O.; Cavett, V.; Nowak, J.; Garcia-Ordonez, R. D.; Houtman, R.; Griffin, P. R.; Kojetin, D. J.; Katzenellenbogen, J. A.; Conkright, M. D.; Nettles,  K. W. “Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network.” eLife 2014, 3, e02057. PMID: 24771768

• Pollock, J. A.; Larrea, M. D.; Jasper, J. S.; McDonnell, D. P.; McCafferty, D. G. “Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and independent manners.” ACS Chem. Biol. 2012, 7, 1221-1231. PMID: 22533360

• Gooden, D. M.; Schmidt, D. M. Z.; Pollock, J. A.; Kabadi, A. M.*; McCafferty, D. G. “Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B.”  Bioorg. Med. Chem. Lett. 2008, 18, 3047-3051. PMID: 18242989

• Pollock, J. A.*; Clark, K. M.*; Martynowicz, B. J.*; Pridgeon, M. G.*; Rycenga, M. J.*; Stolle, K. E.*; Taylor, S. K. “A mild biosynthesis of lactones via enantioselective hydrolysis of hydroxynitriles.” Tetrahedron: Asymmetry. 2007, 18, 1888-1892.

* indicates undergraduate author

• Katzenellenbogen, J.; McDonnell, D.; Norris, J.; Parent, A.; Pollock, J.; Gunther, J.; Carlson, K.; Martin, T. “Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer.” Application No. 14/57391. Publication No. WO 2015/048246.

• McCafferty, D. G.; Pollock, J. A.; Gooden, D. M.; Caron, M. G.; Gainetdinov, R. R.; Sotnikova, T. D. “Methods for the treatment using arylcyclopropylamine compounds.” Application No. 13/723,971. Publication No. US 2013/0178520 A1.

• McCafferty, D. G.; Pollock, J. A. “Arylcyclopropylamines and methods of use.” Application No. 12/792,316. Publication No. US 2010/0324147 A1.